| Vaccines for pneumonia and new antiviral therapies. | |
| | |
MedLine Citation:
|
PMID: 11680115 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Influenza and pneumococcal diseases are preventable to a large extent. The Health Care Financing Agency of Medicare and the Joint Commission on Accreditation of Healthcare Organizations have made prevention of these two diseases a top priority. Immunization should remain the primary tool for prevention. When influenza epidemics appear, practitioners should be aware that effective drugs are available to treat influenza A or B if given promptly after the onset of illness. |
| | |
Authors:
|
P A Gross |
Related Documents
:
|
11464425 - Decomposing pharmaceutical cost growth in different types of health plans. 16502815 - Pfizer and humana join forces on new medicare health support program. 10158735 - An analysis of selectivity bias in the medicare aapcc (adjusted average per capita cost). 10127415 - Physician self-referral on the fast track. 2379375 - Credentialing for international fellowships. 10337085 - Health consciousness of young people in relation to their personality. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Medical clinics of North America Volume: 85 ISSN: 0025-7125 ISO Abbreviation: Med. Clin. North Am. Publication Date: 2001 Nov |
Date Detail:
|
Created Date: 2001-10-26 Completed Date: 2001-12-04 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 2985236R Medline TA: Med Clin North Am Country: United States |
Other Details:
|
Languages: eng Pagination: 1531-44 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA. pgross237@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetamides
/
therapeutic use Adult Aged Amantadine / therapeutic use Antiviral Agents / adverse effects, therapeutic use* Centers for Medicare and Medicaid Services (U.S.) Child Guanidines Health Priorities Humans Incidence Influenza Vaccines Joint Commission on Accreditation of Healthcare Organizations Morbidity Neuraminidase / antagonists & inhibitors Oseltamivir Patient Selection Pneumococcal Vaccines Pneumonia / epidemiology, immunology, prevention & control* Primary Prevention / methods Pyrans Rimantadine / therapeutic use Safety Sialic Acids / therapeutic use United States / epidemiology Vaccination / adverse effects, methods* World Health Zanamivir |
| Chemical | |
Reg. No./Substance:
|
0/Acetamides; 0/Antiviral Agents; 0/Guanidines; 0/Influenza Vaccines; 0/Oseltamivir; 0/Pneumococcal Vaccines; 0/Pyrans; 0/Sialic Acids; 13392-28-4/Rimantadine; 139110-80-8/Zanamivir; 768-94-5/Amantadine; EC 3.2.1.18/Neuraminidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nonresolving pneumonia and mimics of pneumonia.
Next Document: Risk factors for nosocomial pneumonia. Focus on prophylaxis.